Literature DB >> 1508220

Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast.

T A Pham1, Y P Hwung, D Santiso-Mere, D P McDonnell, B W O'Malley.   

Abstract

The estrogen receptor (ER) is a transcription factor involved in steroid hormone signal transduction in higher eukaryotes. The receptor also functions as a ligand-dependent transcriptional activator when introduced into Saccharomyces cerevisiae (baker's yeast), which suggests that at least some of the components of the signal transduction pathway are conserved between yeast and mammalian cells, and, moreover, allows the possibility of using this simple eukaryotic organism to dissect receptor function. However, whether the ER actually activates transcription in a mechanistically similar fashion in yeast and mammalian cells is unclear, since it has been reported that the transactivation function within the hormone binding domain (TAF-2) does not function in yeast. In this report, we have characterized the activity of the transactivation functions of the ER in yeast. Our results indicate that both TAF-2 and the N-terminal transactivation region (TAF-1) are functional in yeast and contribute synergistically to the receptor's total activity. These results are consistent with those obtained in mammalian cells. Furthermore, we show that in yeast the antagonistic effects of the antiestrogen nafoxidine arise from a modulation of the synergistic interactions of TAF-1 and TAF-2, and not simply from an inactivation of TAF-2 by antihormone. Finally, we characterize the effect of ER deletion mutants on chromatin structure in yeast. Our data lend support to the view that the formation of competent transcriptional initiation complexes requires a precise disruption of chromatin structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508220     DOI: 10.1210/mend.6.7.1508220

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

1.  Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element.

Authors:  H Chen; J E Arbelle; M A Gacad; E A Allegretto; J S Adams
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Phosphorylation of serine-167 on the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation.

Authors:  E Castaño; D P Vorojeikina; A C Notides
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

3.  Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1.

Authors:  G Flouriot; H Brand; S Denger; R Metivier; M Kos; G Reid; V Sonntag-Buck; F Gannon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.

Authors:  C y Chang; J D Norris; H Grøn; L A Paige; P T Hamilton; D J Kenan; D Fowlkes; D P McDonnell
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.

Authors:  E M McInerney; M J Tsai; B W O'Malley; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Histone H2A.Z is essential for estrogen receptor signaling.

Authors:  Nicolas Gévry; Sara Hardy; Pierre-Etienne Jacques; Liette Laflamme; Amy Svotelis; François Robert; Luc Gaudreau
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

7.  The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Authors:  S A Fuqua; D C Allred; R M Elledge; S L Krieg; M G Benedix; Z Nawaz; B W O'Malley; G L Greene; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Reconstitution of retinoid X receptor function and combinatorial regulation of other nuclear hormone receptors in the yeast Saccharomyces cerevisiae.

Authors:  B L Hall; Z Smit-McBride; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

9.  Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.

Authors:  Kristi L Hoffman; Seth P Lerner; Carolyn L Smith
Journal:  Horm Cancer       Date:  2012-09-11       Impact factor: 3.869

10.  Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.

Authors:  F Wang; D Hoivik; R Pollenz; S Safe
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.